Exchange: OTC·Updated 10:01 AM EDT

HLBBF H. Lundbeck AS - Ordinary Shares - Class B

$6.96
$0.32
(4.82%)
Today
EarningsNov 11
Mkt Cap$6.91B
Vol250.00

About HLBBF

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
50

Neutral Sentiment

How do you feel about HLBBF?

Advertisement|Remove ads.